AAIC 2017 | Biomarkers: an important tool in the characterization of dementia
Ian McKeith
Ian McKeith, FMedSci, MD, FRSB, FRCPsych from Newcastle University, Newcastle, UK talks to us the importance of biomarkers in the characterization of patients suffering from dementia, and discusses a common misunderstanding about their use for this purpose. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.
Related videos
1:38
CT1812: exciting preliminary results
Susan Catalano
1:20
Therapeutics designed to mimic protective mutations for Alzheimer's disease
Susan Catalano
3:00
A673T mutation lowers Aβ oligomer binding affinity: Alzheimer’s disease protective mechanism
Susan Catalano
2:02
The role of phosphorylated tau in clinical trials
Elisabeth Thijssen
2:33
Using phosphorylated tau as a diagnostic tool for Alzheimer's disease
Elisabeth Thijssen
